Molecules Conchem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 30-07-2024
- Paid Up Capital ₹ 1.00 M
as on 30-07-2024
- Company Age 8 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.40 Cr
as on 30-07-2024
- Satisfied Charges ₹ 2.00 M
as on 30-07-2024
- Revenue 44.12%
(FY 2023)
- Profit 11.16%
(FY 2023)
- Ebitda 12.91%
(FY 2023)
- Net Worth 22.28%
(FY 2023)
- Total Assets 6.22%
(FY 2023)
About Molecules Conchem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹6.40 Cr. The company has closed loans amounting to ₹2.00 M, as per Ministry of Corporate Affairs (MCA) records.
Guriqbal Cheema, Harpreet Kaur, and Sumanjeet Kaur serve as directors at the Company.
- CIN/LLPIN
U24306HR2016PTC065366
- Company No.
065366
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Jind, Haryana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Molecules Conchem Private Limited offer?
Molecules Conchem Private Limited offers a wide range of products and services, including Concrete Admixture, Superplasticizer Admixture.
Who are the key members and board of directors at Molecules Conchem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Guriqbal Cheema  | Director | 10-Aug-2016 | Current |
| Harpreet Kaur | Director | 10-Aug-2016 | Current |
| Sumanjeet Kaur | Director | 10-Aug-2016 | Current |
Financial Performance of Molecules Conchem.
Molecules Conchem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.12% increase. The company also saw a substantial improvement in profitability, with a 11.16% increase in profit. The company's net worth Soared by an impressive increase of 22.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Molecules Conchem?
In 2023, Molecules Conchem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Apr 2024 | ₹1.35 Cr | Open |
Hdfc Bank Limited Creation Date: 22 Jan 2024 | ₹4.00 Cr | Open |
Others Creation Date: 27 Apr 2019 | ₹1.05 Cr | Open |
How Many Employees Work at Molecules Conchem?
Unlock and access historical data on people associated with Molecules Conchem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Molecules Conchem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Molecules Conchem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
